Persisting Helicobacter antibodies in Finnish children and adolescents between two and twenty years of age

Pediatric Infectious Disease Journal

Volumn 17, Issue 9, 1998, Pages 796-799

  Rehnberg Laiho, Leena ^a   Rautelin, Hilpi ^a   Valle, Martti ^b   Kosunen, Timo U ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antibodies; Children; Epidemiology; Follow up; Helicobacter pylori

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FINLAND; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FINLAND; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; SEROEPIDEMIOLOGIC STUDIES;

EID: 0031691997     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809000-00009     Document Type: Article

References (26)

1. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
2. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
3. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59.
4. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
5. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
6. Fraser AG, Scragg R, Metcalf P, McCullough S, Yeates NJ. Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust NZ J Med 1996;26:646-51.
7. Graham DY, Malaty HD, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and sosioeconomic status. Gastroenterology 1991;1001:1495-501.
8. Malaty HM, Graham DY. Importance of childhood sosioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742-5.
9. McCallion WA, Murray LJ, Bailie AG, Dalzell AM, O'Reilly DPJ, Bamford KB. Helicobacter pylori infection in children: relation with current household living conditions. Gut 1996; 39:18-21.
10. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;339:896-7.
11. Webb PM, Knight T, Greaves S, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. Br Med J 1994;308:750-3.
12. Teh BH, Lin JT, Pan WH, et al. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res 1994;14:1389-92.
13. Blecker U, Hauser B, Lanciers S, Peeters S, Suys B, Vandenplas Y. The prevalence of Helicobacter pylori-positive serology in asymptomatic children. J Pediatr Gastroenterol Nutr 1993;16:252-6.
14. Granström M, Tindberg Y, Blennow M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol 1997;35:468-70.
15. Klein PD, Gilman RH, Leon-Barua R, et al. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol 1994;89:2196-9.
16. Ashorn M, Miettinen A, Ruuska T, Laippala P, Mäki M. Seroepidemiological study of Helicobacter pylori infection in infancy. Arch Dis Child 1996;74:F141-2.
17. Blecker U, Lanciers S, Hauser B, Vandenplas Y. The prevalence of Helicobacter pylori positivity in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol 1994;47:1095-8.
18. Adler-Shohet F, Palmer P, Reed G, Edwards K. Prevalence of Helicobacter pylori antibodies in normal children. Pediatr Infect Dis J 1996;15:172-3.
19. Ashorn M, Mäki M, Hällström M, et al. Helicobacter pylori infection in Finnish children and adolescents. Scand J Gastroenterol 1995;30:876-9.
20. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994;331: 1397-402.
21. Andersen LP, Raskov H, Elsborg L, et al. Prevalence of antibodies against heat-stable antigens from Helicobacter pylori in patients with dyspeptic symptoms and normal persons. APMIS 1992;100:779-89.
22. Crabtree JE, Mahony MJ, Taylor JD, Heatley RV, Littlewood JM, Tompkins DS. Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol 1991;44:768-71.
23. Langenberg W, Rauws EA, Houthoff HJ, et al. Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis 1988;157:1245-9.
24. Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
25. Veenendal RA, Pena AS, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991;32:1291-4.
26. Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31.